世界の呼吸器インターベンション市場は72億ドルに達すると予想され、肺がんの発生増加が呼吸器インターベンション市場の成長を後押ししているため、予測期間中に6.5％のCAGRで成長する見込みです。政府や医療提供者による喘息、COPD、その他の肺疾患に関するいくつかの啓発キャンペーンが、インターベンショナル呼吸器科市場の成長を推進しています。電磁ナビゲーション気管支鏡検査は高額な診療報酬を節約できるため、呼吸器インターベンション市場の成長を促進する可能性があります。病院や小売店とのパートナーシップは、この市場の主要企業が採用しているマーケティング戦略です。
目次
1.Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Interventional Pulmonology Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Global Interventional Pulmonology Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Global Interventional Pulmonology Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Global Interventional Pulmonology Market
10.1.Overview
10.2.Historical Analysis (2016-2021)
10.2.1.Market Size, Y-o-Y Growth (%) and Market Forecast
11. Global Interventional Pulmonology Market Size & Forecast 2022A-2032F
11.1.Overview
11.2.Key Findings
11.3. Market Segmentation
11.3.1.By Product Type
11.3.1.1.Bronchoscopes
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Electromagnetic Navigation Bronchoscopy Systems
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Pleuroscopes
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Respiratory Endotherapy Devices
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Airway Stents
11.3.1.5.1. By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Pleural Catheters
11.3.1.6.1. By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Endobronchial Valves
11.3.1.7.1. By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.8.Bronchial Thermoplasty Systems
11.3.1.8.1. By Value (USD Million) 2022-2032F
11.3.1.8.2. Market Share (%) 2022-2032F
11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.By Indication
11.3.2.1.Asthma
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2.Chronic Obstructive Pulmonary Disease
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3.Lung Cancer
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.4.Tracheal & Bronchial Stenosis
11.3.2.4.1. By Value (USD Million) 2022-2032F
11.3.2.4.2. Market Share (%) 2022-2032F
11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.5.Others
11.3.2.5.1. By Value (USD Million) 2022-2032F
11.3.2.5.2. Market Share (%) 2022-2032F
11.3.2.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.By End User
11.3.3.1.Hospitals
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2.Ambulatory Surgical Canters
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3.Diagnostic Canters
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.4.Surgical Clinics
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Interventional Pulmonology Market Size & Forecast 2022A-2032F
12.1.Overview
12.2.Key Findings
12.3.Market Segmentation
12.3.1.By Product Type
12.3.2.By Indication
12.3.3.By End User
12.4.Country
12.4.1.United States
12.4.2.Canada
13. Europe Interventional Pulmonology Market Size & Forecast 2022A-2032F
13.1.Overview
13.2.Key Findings
13.3.Market Segmentation
13.3.1.By Product Type
13.3.2.By Indication
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4.Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Interventional Pulmonology Market Size & Forecast 2022A-2032F
14.1.Overview
14.2.Key Findings
14.3.Market Segmentation
14.3.1.By Product Type
14.3.2.By Indication
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2.China
14.4.3.South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15. Middle East and Africa Interventional Pulmonology Market Size & Forecast 2022A-2032F
15.1.Overview
15.2.Key Findings
15.3. Market Segmentation
15.3.1.By Product Type
15.3.2.By Indication
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16. Latin America Interventional Pulmonology Market Size & Forecast 2022A-2032F
16.1.Overview
16.2.Key Findings
16.3.Market Segmentation
16.3.1.By Product Type
16.3.2.By Indication
16.3.3.By End User
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. Competitive Landscape
17.1.Company market share, 2021
17.2.Key player overview
17.3.Key stakeholders
18. Company Profiles
18.1. Boston Scientific Corporation
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.1.4.5.Executive Team
18.2. Dickinson and Company
18.3. HUGER Medical Instrument Co., Ltd.
18.4. Smiths Group plc.
18.5. Cook Medical
18.6. Olympus Corporation
18.7. FUJIFILM Corporation
18.8. Richard Wolf Corporation
18.9. Karl Storz
18.10.Taewoong Medical Co., Ltd
18.11.Vygon
18.12.PENTAX Medical
18.13.Clarus Medical LLC
18.14.Other Prominent Players
19. Appendix
20. Consultant Recommendation
